Ensaios Clínicos

Estamos comprometidos em trazer melhores opções de tratamento aos pacientes do mundo inteiro.

Estamos recrutando para ensaios clínicos uma ampla gama de indicações terapêuticas, incluindo linfoma, câncer de fígado, câncer de pulmão, câncer gástrico, câncer de mama, e muito mais.

Questions about a clinical trial?

If you are a patient or a health care provider and would like more information about a clinical trial, please contact our research team.

Search Clinical Trials

  • Age
  • Available Documents
  • Patient Level Data Anonymized patient level data for select studies available to qualified scientific researchers
  • Phases <strong>Phase 1:</strong> A step in clinical research to focus on the safety of a drug and how it works in the body.

<strong>Phase 2:</strong> A step in clinical research to gather data on whether a drug works in people who have a certain condition or disease.

<strong>Phase 3:</strong> A step in clinical research that gathers more information about a drug’s safety and if it works in people.

<strong>Phase 4:</strong> A step in clinical research after regulatory authorities have approved a drug for marketing.

<strong>N/A:</strong> For observational studies or interventional studies that do not support drug development.
  • Results
  • Sex In this context, a person’s sex refers to that person’s assigned sex at birth. This has been the case historically; however, there is growing understanding in the healthcare community that this definition excludes certain segments of the population and should be expanded, where possible, to account for gender identity as well. BeiGene recognizes the importance of making clinical trials accessible to all groups of people and is committed to promoting inclusive research.
  • Study Status <strong>Recruiting:</strong> The study is open to enrollment for qualified participants.

<strong>Will be Recruiting:</strong> The study has not yet opened enrollment for qualified participants.

<strong>Recruitment Complete:</strong> The study is ongoing, and participants are receiving an intervention or being examined, but new potential participants are not currently being recruited or enrolled.

<strong>Completed:</strong> The study has ended normally, and participants are no longer receiving an intervention or being examined.

<strong>Other:</strong> All other study statuses such as withdrawn, canceled, or terminated.
  • Study Type <strong>Expanded Access:</strong> A way for patients with serious diseases or conditions who cannot participate in a clinical study to gain access to a medical product that has not been approved by regulatory authorities. Also called compassionate use.

<strong>Interventional:</strong> A type of clinical trial in which participants are assigned to groups that receive one or more treatment or study drug (intervention).

<strong>Observational:</strong> A type of clinical study in which participants may receive diagnostic or study drugs but the study investigator does not assign participants to a a specific intervention or treatment.
  • Vaccine Studies
Clear

Search Results

Study ID
Phase
Condition(s)
Status
Sex
Age Range

BGB-11417-105 U1111-1277-5444

1/2

Relapsed/Refractory Multiple Myeloma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-11417-105 U1111-1277-5444

Recruiting

Phase

1/2

Condition

Relapsed/Refractory Multiple Myeloma

Sex

All

Age

18 Years and older   (Adult, Older Adult)


AdvanTIG-206

2

Advanced Hepatocellular Carcinoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

AdvanTIG-206

Recruiting

Phase

2

Condition

Advanced Hepatocellular Carcinoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-A317-Sitravatinib 301

3

Non-Small Cell Lung Cancer (NSCLC)

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-Sitravatinib 301

Recruiting

Phase

3

Condition

Non-Small Cell Lung Cancer (NSCLC)

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-11417-102

1

Mature B-cell Malignancies

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-11417-102

Recruiting

Phase

1

Condition

Mature B-cell Malignancies

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-A317-A1217-301

3

Non Small Cell Lung Cancer

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-A1217-301

Recruiting

Phase

3

Condition

Non Small Cell Lung Cancer

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-11417-103

1/2

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative Neoplasm

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-11417-103

Recruiting

Phase

1/2

Condition

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative Neoplasm

Sex

All

Age

18 Years and older   (Adult, Older Adult)


AdvanTIG-302 BGB-A317-A1217-302

3

Non-small Cell Lung Cancer | NSCLC

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

AdvanTIG-302 BGB-A317-A1217-302

Recruiting

Phase

3

Condition

Non-small Cell Lung Cancer | NSCLC

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-A317-A1217-203

2

Esophageal Squamous Cell Carcinoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-A1217-203

Recruiting

Phase

2

Condition

Esophageal Squamous Cell Carcinoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-A317-fruquintinib-201

2

Advanced Solid Tumors

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-fruquintinib-201

Recruiting

Phase

2

Condition

Advanced Solid Tumors

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-A317-15025-101

1

Advanced Solid Tumor

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-15025-101

Recruiting

Phase

1

Condition

Advanced Solid Tumor

Sex

All

Age

18 Years and older   (Adult, Older Adult)


Perguntas sobre um ensaio clínico?

Se você é um paciente ou um provedor de saúde e gostaria de mais informações sobre um ensaio clínico, por favor, entre em contato com nossa equipe de pesquisa.

O que são ensaios clínicos?

Um ensaio clínico é um tipo de estudo de pesquisa projetado para determinar se um medicamento de pesquisa funciona e é seguro para as pessoas. Um regulador governamental, como a FDA (Food and Drug Administration) dos EUA, a NMPA (China National Medical Products Administration), e outros devem aprovar os ensaios clínicos antes de poderem começar. Os dados coletados dos ensaios clínicos são então analisados pelos reguladores governamentais para ver se eles estão ajudando as pessoas e se são seguros antes de aprovarem um novo medicamento para uso pelo público em geral.

Fases dos ensaios clínicos

Os ensaios clínicos são feitos em várias etapas chamadas “fases”. Cada fase clínica tem um propósito diferente e ajuda os pesquisadores a responder perguntas sobre o medicamento que está sendo testado, tais como qual é a melhor dose do medicamento a ser usada, e como funciona?

Participando de um ensaio clínico

Se você estiver pensando em participar de um ensaio clínico, uma equipe de profissionais avaliará se você é um bom candidato para um estudo específico. Participar de um ensaio clínico é diferente do atendimento médico regular. Você estará em contato com a equipe do estudo que inclui o médico do estudo, enfermeiros e coordenadores de pesquisa. Pessoas de todas as idades, gêneros, raças e grupos étnicos podem participar de ensaios clínicos. Isto inclui voluntários saudáveis e pacientes com diagnósticos específicos. Veja abaixo para saber mais sobre o processo de participação em um ensaio clínico e o que esperar.